article thumbnail

Sesame Allergies Cause FDA to List Sesame as the 9th Major Allergen

XTalks

The US Food and Drug Administration (FDA) has added sesame to its list of major allergens, making it easier for people with sesame allergies to safely consume packaged food without fear of an allergic reaction. Beginning this year, all food and dietary supplement manufacturers must clearly list sesame as an ingredient on product labels.

article thumbnail

Pfizer signs deal with Gilead to manufacture COVID-19 antiviral remdesivir

pharmaphorum

Pfizer has signed a multi-year agreement with Gilead to manufacture and supply the COVID-19 antiviral remdesivir, which is also being tested in combination with other drugs in an effort to fight the pandemic. Pfizer will provide contract manufacturing services at its facility in McPherson, Kansas, to supply the drug to Gilead.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Camallergy’s UK Based Manufacturing Facility Receives cGMP Licences for Peanut Allergy Treatment

The Pharma Data

This clearance is a pivotal regulatory milestone that further supports Camallergy’s leadership and capabilities in the field of peanut allergy immunotherapy with the only cGMP-certified manufacturing facility in Europe producing peanut oral immunotherapy,” said Sherden Timmins, Chief Technology Officer. 8, 2021 07:00 UTC.

article thumbnail

GreenLight and US NIH partner to develop Covid-19 vaccine for variants

Pharmaceutical Technology

The company will jointly design and analyse messenger ribonucleic acid (mRNA) Covid-19 vaccines in partnership with the NIH unit National Institute of Allergy and Infectious Diseases’ Vaccine Research Center (VRC). In November last year, GreenLight and Samsung Biologics entered a collaboration agreement to manufacture mRNA Covid-19 vaccines.

article thumbnail

Allergy specialist Stallergenes taps Aptar for digital delivery

pharmaphorum

AIT involves the administration of controlled, low doses of allergens under the tongue or by subcutaneous injection in people with allergies, with the aim of desensitising the immune system to them and prevent allergic reactions. ” The post Allergy specialist Stallergenes taps Aptar for digital delivery appeared first on.

article thumbnail

Camallergy’s UK Based Manufacturing Facility Receives cGMP Licences for Peanut Allergy Treatment

BioTech 365

Camallergy’s UK Based Manufacturing Facility Receives cGMP Licences for Peanut Allergy Treatment Camallergy’s UK Based Manufacturing Facility Receives cGMP Licences for Peanut Allergy Treatment -Only European cGMP-certified manufacturing facility for peanut allergy oral immunotherapy -Facility to supply drug product for … Continue reading → (..)

article thumbnail

UCB sells off production plant and a clutch of older meds in China for $680M

Fierce Pharma

Restructuring seems to be the name of the game for many large drugmakers these days, and Belgium-based UCB is no except | Belgium’s UCB is selling off its mature neurology and allergy business—plus a manufacturing plant—in mainland China.

Allergies 102